Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.
Company profile
Ticker
CHE
Exchange
Website
CEO
Kevin McNamara
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ROTO-ROOTER INC
SEC CIK
Corporate docs
Subsidiaries
Chemed RT, Inc. • Comfort Care Holdings Co. • Consolidated HVAC, Inc. • Jet Resource, Inc. • Nurotoco of Massachusetts, Inc. • Nurotoco of New Jersey, Inc. • Roto RT, Inc. • Roto-Rooter Canada, Ltd. • Roto-Rooter Corporation • Roto-Rooter Group, Inc. ...
IRS number
310791746
CHE stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
16 May 23
10-Q
2023 Q1
Quarterly report
28 Apr 23
8-K
Chemed Reports First-Quarter 2023 Results
26 Apr 23
ARS
2023 FY
Annual report to shareholders
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
8-K
Chemed Reports Fourth-Quarter 2022 Results
23 Feb 23
8-K
Amendments to Articles of Incorporation or Bylaws
9 Dec 22
8-K/A
Departure of Directors or Certain Officers
7 Nov 22
10-Q
2022 Q3
Quarterly report
2 Nov 22
Transcripts
CHE
Earnings call transcript
2023 Q1
27 Apr 23
CHE
Earnings call transcript
2022 Q4
24 Feb 23
CHE
Earnings call transcript
2022 Q3
1 Nov 22
CHE
Earnings call transcript
2022 Q2
28 Jul 22
CHE
Earnings call transcript
2022 Q1
27 Apr 22
CHE
Earnings call transcript
2021 Q4
25 Feb 22
CHE
Earnings call transcript
2021 Q3
29 Oct 21
CHE
Earnings call transcript
2021 Q2
28 Jul 21
CHE
Earnings call transcript
2021 Q1
29 Apr 21
CHE
Earnings call transcript
2020 Q4
24 Feb 21
Latest ownership filings
144
Notice of proposed sale of securities
1 Jun 23
4
Nicholas Michael Westfall
1 Jun 23
144
Notice of proposed sale of securities
30 May 23
4
PATRICK P GRACE
30 May 23
144
Notice of proposed sale of securities
26 May 23
4
Eileen P McCarthy
18 May 23
3
Eileen P McCarthy
18 May 23
4
GEORGE J WALSH III
16 May 23
4
THOMAS P RICE
16 May 23
4
John Meredith Jr. Mount
16 May 23
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 58.05 mm | 58.05 mm | 58.05 mm | 58.05 mm | 58.05 mm | 58.05 mm |
| Cash burn (monthly) | 5.36 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 11.12 mm | n/a | n/a | n/a | n/a | n/a |
| Cash remaining | 46.94 mm | n/a | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 8.8 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2023
94.6% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 440 |
| Opened positions | 54 |
| Closed positions | 44 |
| Increased positions | 147 |
| Reduced positions | 157 |
| 13F shares | Current |
|---|---|
| Total value | 7.26 tn |
| Total shares | 14.21 mm |
| Total puts | 3.40 k |
| Total calls | 11.70 k |
| Total put/call ratio | 0.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 1.70 mm | $912.60 bn |
| BLK Blackrock | 1.39 mm | $749.90 bn |
| William Blair Investment Management | 560.74 k | $301.54 bn |
| Neuberger Berman | 532.71 k | $286.46 bn |
| Kayne Anderson Rudnick Investment Management | 510.33 k | $274.43 bn |
| Envestnet Asset Management | 477.84 k | $26.49 bn |
| STT State Street | 442.36 k | $237.88 bn |
| Wellington Management | 384.74 k | $206.90 bn |
| MS Morgan Stanley | 366.21 k | $196.93 bn |
| AMP Ameriprise Financial | 345.29 k | $185.67 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jun 23 | Westfall Nicholas Michael | capital stock | Option exercise | Acquire M | No | No | 413.19 | 1,330 | 549.54 k | 7,676 |
| 1 Jun 23 | Westfall Nicholas Michael | stock option(right to buy with tandem tax withholding) capital stock | Option exercise | Dispose M | No | No | 413.19 | 1,330 | 549.54 k | 59,069 |
| 30 May 23 | Westfall Nicholas Michael | capital stock | Sell | Dispose S | No | No | 540.34 | 1,330 | 718.65 k | 6,346 |
| 26 May 23 | Grace Patrick P | capital stock | Sell | Dispose S | No | No | 544.24 | 294 | 160.01 k | 3,270 |
| 15 May 23 | Ron DeLyons | capital stock | Grant | Acquire A | No | No | 545.69 | 294 | 160.43 k | 1,105 |
| 15 May 23 | Grace Patrick P | capital stock | Grant | Acquire A | No | No | 545.69 | 294 | 160.43 k | 3,564 |
| 15 May 23 | Christopher J Heaney | capital stock | Grant | Acquire A | No | No | 545.69 | 294 | 160.43 k | 1,828 |
News
Tuesday Is Your Last Chance To Buy Chemed Before The Dividend Payout
19 May 23
Saia To Rally Around 33%? Here Are 10 Other Analyst Forecasts For Monday
1 May 23
RBC Capital Maintains Outperform on Chemed, Raises Price Target to $610
1 May 23
Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $610
28 Apr 23
Chemed Q1 EPS $4.82 Beats $4.81 Estimate, Sales $560.16M Beat $548.78M Estimate
26 Apr 23
Press releases
Chemed Corporation to Present at the Jefferies 2023 Healthcare Conference
1 Jun 23
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
15 May 23
Chemed Corporation to Present at the 2023 RBC Global Healthcare Conference
10 May 23
Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference
3 May 23
Chemed Reports First-Quarter 2023 Results
26 Apr 23